This supplementary information contains additional physicochemical stability data of liposomes manufactured with various concentrations of TLR ligands (Figures S1-S3 ). Also included is physicochemical compatibility data of the adjuvant formulations with the recombinant LecA vaccine antigen ( Figure S4 ) and representative flow cytometry gating strategy ( Figure S5 ).
In some cases at the 37°C storage conditions, formulations failed visual stability testing (due to visual inhomogeneities) and were not measured for particle size at 9 or 12 months. Months at 5°C
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